Brief: Xbrane Biopharma Q4 EBITDA Loss Narrows To SEK 28.2 Million

Xbrane Biopharma AB

24/02/2022 07:17

Feb 24 (Reuters) - Xbrane Biopharma AB  XBRANE.ST :
    * Q4 EBITDA LOSS SEK 28.2 MILLION VERSUS LOSS SEK 61.3
MILLION
YEAR AGO
    * Q4 REVENUE SEK 0.0 MILLION VERSUS SEK 0.0 MILLION YEAR AGO

Source text for Eikon:  ID:nMFN8rr1vM 
Further company coverage:  XBRANE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))